Tonix Pharmaceuticals Holding Investor Relations Material
Latest events
Status Update
Tonix Pharmaceuticals Holding
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tonix Pharmaceuticals Holding Corp
Access all reports
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing therapies for central nervous system disorders, rare diseases, and infectious diseases. The company’s pipeline includes treatments for conditions such as post-traumatic stress disorder (PTSD), fibromyalgia, and long COVID. Tonix Pharmaceuticals also explores vaccine and antiviral drug candidates for infectious disease prevention and treatment. The company is headquartered in Chatham, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Tonix Pharmaceuticals Holding Corp
Corporate Presentation
Tonix Pharmaceuticals Holding Corp
Investor Presentation
Tonix Pharmaceuticals Holding Corp
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
TNXP
Country
🇺🇸 United States